COMP <GO>
JBTM vs NOVT // EV/EBITDA & P/E VALUATION
JBT Marel Corporation (NYSE) VS. Novanta Inc. (NASDAQ) • 15-METRIC TALLY: JBTM 5
— NOVT 9
▲ EV/EBITDA & P/E VALUATION LEADER: JBTM
LAST: $110.44 (+2.64%) • MKT CAP: $5.73B
valuation
21.0x
LAST: $151.18 (+0.35%) • MKT CAP: $5.72B
valuation
51.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (JBTM VS. NOVT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | JBTM | NOVT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 35.10% | 44.40% | -9.30 | NOVT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.60% | 6.50% | -3.90 | NOVT | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 21.0x | 51.7x | -30.70 | JBTM | /valuation <GO> |
| Free Cash Flow Yield | -3.99% | 0.85% | -4.84 | NOVT | /fcf-yield <GO> |
| Operating Margin | 5.00% | 9.60% | -4.60 | NOVT | /operating-margins <GO> |
| Net Profit Margin | -1.30% | 5.50% | -6.80 | NOVT | /net-margins <GO> |
| Revenue Growth (YoY) | 121.30% | 3.30% | +118.00 | JBTM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.36% | 0.00% | +0.36 | JBTM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.66 | 8.30 | -6.64 | NOVT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | NOVT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.2 | 58.2 | -4.00 | NOVT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | 1.01 | -0.02 | NOVT | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.0x | 98.8x | -80.80 | JBTM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.73B | $5.72B | $12.0M | JBTM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | JBTM REV | NOVT REV | JBTM GROSS % | NOVT GROSS % | JBTM FCF | NOVT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.80B | $980.6M | 35.1% | 44.4% | — | $48.4M |
| FY 2024 | $1.72B | $949.2M | 36.5% | 44.4% | — | $141.3M |
| FY 2023 | $1.66B | $881.7M | — | — | — | $80.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
JBTM // BETA 0.99
NOVT // BETA 1.01